Author:
Armbrust W.,Kamphuis S. S. M.,Wolfs T. W. F.,Fiselier T. J. W.,Nikkels P. G.,Kuis W.,Wulffraat N. M.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Reference9 articles.
1. Kimura Y, Imundo L, Li SC. High dose infliximab in the treatment of resistant systemic juvenile rheumatoid arthritis. Arthritis Rheum2000;43(Suppl.):1316.
2. Kietz DA, Pepmueller PH, Moore TL. Clinical response to etanercept in polyarticular course juvenile rheumatoid arthritis. J Rheumatol2001;28:360–2.
3. Lovell DJ, Giannini EH, Reiff A et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med2000;342:763–9.
4. Keane J, Gershon S, Wise RP et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med2001;345:1098–104.
5. Myers A, Clark J, Foster H. Tuberculosis and treatment with infliximab. N Engl J Med 2002;346:623–6.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献